US00687W1099
© Newsfile
28.01.2026
ADIA
LISTED
OTC
Adia Nutrition Announces Documentary Featuring WWE/TNA Superstar Elias/Elijah Jeff Sciullo's Recovery with Adia Med's AdiaVita Stem Cell Treatment
News Preview
Winter Park, Florida--(Newsfile Corp. - January 28, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in regenerative therapies, is proud to announce an upcoming documentary chronicling the recovery of professional wrestler Jeff Sciullo—known to fans as Elias in WWE and Elijah in TNA—from a tr...
Themefolio
Profiler
Peergroup
© Newsfile
26.01.2026
ADIA
LISTED
OTC
Adia Nutrition Announces Every Child in Autism Stem Cell Study Receives Umbilical Cord Blood-Derived Stem Cell Treatments Three Times - Open Nationwide and Worldwide with Participation Cost
News Preview
Winter Park, Florida--(Newsfile Corp. - January 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its subsidiary Adia Med of Winter Park, LLC, today highlighted key details of its ongoing IRB-approved clinical study for children with Autism Spectrum Disorder (ASD), listed on ClinicalTrials.gov (NCT07304440). The trial ensures every participati...
Themefolio
Profiler
Peergroup
© Newsfile
20.01.2026
ADIA
LISTED
OTC
Adia Nutrition Inc. Receives Notification from SEC: Form 10 to Become Effective on February 3, 2026
News Preview
Winter Park, Florida--(Newsfile Corp. - January 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and personalized healthcare, today announced that it has been notified by the U.S. Securities and Exchange Commission (SEC) that its Form 10 registration statement will not be subject to further review. As a result, the F...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Newsfile
15.01.2026
ADIA
LISTED
OTC
Adia Nutrition Promotes Emmanuela Derisbrun, APRN, FNP-C, to Provider Role Amid Growing Patient Demand and Launch of Autism IRB Study
News Preview
Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in advanced regenerative therapies, announces that Emmanuela Derisbrun, APRN, FNP-C, has transitioned from subcontractor to employed provider. This move supports rising patient volume and the launch of A...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© Newsfile
13.01.2026
ADIA
LISTED
OTC
Adia Med Kicks Off Recruitment Today for Innovative Autism Stem Cell Study
News Preview
Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun the recruitment process for a groundbreaking clinical study evaluating the potential benefits of stem cell therapy in children with Autism Spectrum Disorder (ASD). Th...
Themefolio
Profiler
Peergroup
© Newsfile
08.01.2026
ADIA
LISTED
OTC
ADIA Nutrition Appoints Dawn Bell as Chief Revenue Officer to Accelerate Growth and Drive Success Across Physician Network
News Preview
Winter Park, Florida--(Newsfile Corp. - January 8, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a rapidly growing leader in regenerative medicine, today announced the appointment of Dawn Bell as Chief Revenue Officer (CRO) through its subsidiary, ADIA Labs. Ms. Bell brings more than 15 years of proven expertise as a sales strategist in the medical d...
Themefolio
Profiler
Peergroup
© Newsfile
05.01.2026
ADIA
LISTED
OTC
Adia Nutrition Inc. Announces Landmark Autism Spectrum Disorder Clinical Study Now Live on ClinicalTrials.gov
News Preview
Winter Park, Florida--(Newsfile Corp. - January 5, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine through its subsidiary Adia Med, today announced that its patent-pending clinical study targeting Autism Spectrum Disorder (ASD) has gone live on ClinicalTrials.gov, marking a significant advancement in the compa...
Themefolio
Profiler
Peergroup
© Newsfile
29.12.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Recaps Transformative 2025: Explosive Growth, Strategic Focus, and Path to Nasdaq Uplisting
News Preview
Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions, today announced a year-end recap of its pivotal 2025 achievements. The company delivered remarkable financial performance, operational expansion, and strategic milest...
Themefolio
Profiler
Peergroup
© Newsfile
17.12.2025
ADIA
LISTED
OTC
Adia Labs Launches Turnkey Clinic Model for Chiropractic Practices with BoldMD
News Preview
Winter Park, Florida--(Newsfile Corp. - December 17, 2025) - Adia Labs, a division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a strategic marketing partnership with BoldMD, a leading medical marketing and AI technology company focused on longevity and wellness. The partnership is designed to accelerate the nationwide expansion of Axia M...
Themefolio
Profiler
Peergroup
© Newsfile
15.12.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med's Autism Clinical Study
News Preview
Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med subsidiary, today announced that the independent Institutional Review Board (IRB) BeyondBound has approved the company's patent-pending clinical study protocol focused on Autism Spectrum Disorder (AS...
Themefolio
Profiler
Peergroup
© Newsfile
08.12.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Files SEC Form 10 as Strategic Step Toward Full Reporting Status
News Preview
Winter Park, Florida--(Newsfile Corp. - December 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), announced today that, with the assistance of Adia's Chief Financial Officer, and following review by the Company's auditing accountant, its Form 10 registration statement was prepared and submitted by Adia's corporate accountant and legal counsel to the U...
Themefolio
Profiler
Peergroup
© Newsfile
01.12.2025
ADIA
LISTED
OTC
Adia Med Partners with America's #1 Health Talk Show Host, Dr. Asa Andrew, to Bring Breakthrough Stem Cell Therapies to the Spotlight
News Preview
Winter Park, Florida--(Newsfile Corp. - December 1, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), one of the nation's leaders in Stem Cell Technology is excited to announce a partnership with 3X Physician and Multi-Platform Media talk show personality Dr. Asa Andrew (known to his fans as Doctor Asa).Dr. AsaTo view an enhanced version of this graphic,...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
24.11.2025
ADIA
LISTED
OTC
ADIA Nutrition Submits Patent-Pending Autism Protocol for Independent IRB Review - Clinical Study Launch Nears
News Preview
Winter Park, Florida--(Newsfile Corp. - November 24, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) announced today that, following the independent Institutional Review Board's (IRB) acceptance of its initial draft protocol and invitation to submit a final version, the company has now officially delivered the complete, Patent-Pending regenerative proto...
Themefolio
Profiler
Peergroup
© Newsfile
19.11.2025
ADIA
LISTED
OTC
ADIA Nutrition Inc. to Host Webinar on HSCT for MS and Autoimmune Conditions with HSCT Warriors
News Preview
Winter Park, Florida--(Newsfile Corp. - November 19, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) invites all shareholders, supporters, and potential investors to join a live webinar tomorrow, Thursday, November 20, 2025, at 6:30 PM EST, hosted by HSCT Warriors.HSCT WarriorsTo view an enhanced version of this graphic, please visit:https://images.news...
Themefolio
Profiler
Peergroup
© Newsfile
17.11.2025
ADIA
LISTED
OTC
ADIA Nutrition Inc. Requests SIC Code Update to 2836 (Biological Products) with SEC and OTC Markets
News Preview
Winter Park, Florida--(Newsfile Corp. - November 17, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, today announced it has filed with the SEC to update its Standard Industrial Classification (SIC) code from 2834 (Pharmaceutical Preparations) to 2836 (Biological Products, Except Diagnostic) and with OTC Markets to upd...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ADIA
LISTED
OTC
Adia Med Files Provisional Patent for Breakthrough Regenerative Medical Protocol
News Preview
Winter Park, Florida--(Newsfile Corp. - November 12, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced regenerative health solutions, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO) for a novel medical protocol designed to enhance regenerative outcomes.This Pat...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ADIA
LISTED
OTC
Game-Changing Alliance: Adia Labs and Axia
News Preview
MD Bring Regenerative therapies to Chiropractors Nationwide with Full Physician OversightWinter Park, Florida--(Newsfile Corp. - November 10, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today announced a strategic partnership between its research and development division, Adia Labs, a...
Themefolio
Profiler
Peergroup
© Newsfile
05.11.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Announces Transformative 2025 Milestones and Strategic Progress Toward Nasdaq Uplisting
News Preview
Winter Park, Florida--(Newsfile Corp. - November 5, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today recaps its pivotal year-to-date achievements, marked by explosive revenue growth, strategic divestitures, and decisive steps toward full SEC reporting and a Nasdaq listing.2025 Key Mi...
Themefolio
Profiler
Peergroup
© Newsfile
28.10.2025
ADIA
LISTED
OTC
Adia Nutrition Thrilled to Announce to Shareholders Early Q3 Financials Release and Remarkable 200%+ Revenue Growth
News Preview
Winter Park, Florida--(Newsfile Corp. - October 28, 2025) - Adia Nutrition (OTCQB: ADIA) is thrilled to announce the early release of its Q3 financial results, a powerful testament to the exceptional organization and unwavering commitment of our dynamic team. By unveiling these results weeks ahead of schedule, Adia Nutrition reinforces its dedicati...
Themefolio
Profiler
Peergroup
© Newsfile
21.10.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Appoints Dr. Evan Thomas, MD, PhD, to Drive Adia Med's Specialized Treatment Revolution
News Preview
Winter Park, Florida--(Newsfile Corp. - October 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is excited to announce the appointment of Evan Thomas, MD, PhD, as an Independent Medical Director for its medical division, Adia Med. A renowned radiation oncologist and visionary, Dr. Thomas will oversee clinic practices, including the cutting-edge...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ADIA
LISTED
OTC
Adia Nutrition Paves Way for Nasdaq and New Investors Through SEC Form 10 Submission
News Preview
Winter Park, Florida--(Newsfile Corp. - October 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is thrilled to announce a major milestone in its growth journey. The Company has engaged an independent public accounting firm and securities counsel to prepare and file its Form 10 registration statement with the U.S. Securities and Exchange Commission (S...
Themefolio
Profiler
Peergroup
© Newsfile
08.10.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Delivers Explosive Third Quarter Growth: Revenue Surges Over 100% from Prior Quarter, with Remarkable Profit Margin Exceeding 20%
News Preview
Winter Park, Florida--(Newsfile Corp. - October 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a trailblazer in umbilical cord stem cells and exosome sales and therapies, today announced phenomenal preliminary financial results for the third quarter ended September 30, 2025. The company achieved a monumental revenue increase of more than 100% compar...
Themefolio
Profiler
Peergroup
© Newsfile
06.10.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Divests Biolete Coffee Subsidiary to Cement Factory LLC, Retains 18% Ownership to Support Strategic Focus on Regenerative Medicine and Medical Sales
News Preview
Winter Park, Florida--(Newsfile Corp. - October 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine and innovative healthcare solutions, today announced the sale of its Biolete coffee subsidiary to Cement Factory LLC, a dynamic consumer products firm led by key owners Jeff Sciullo and AJ Sims. Adia will retain...
Themefolio
Profiler
Peergroup
© Newsfile
09.09.2025
ADIA
LISTED
OTC
Adia Nutrition Expands Rapidly, Tripling Sales Force with Regional Teams to Fuel U.S. and Worldwide Growth
News Preview
Winter Park, Florida--(Newsfile Corp. - September 9, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine, is excited to announce a rapid expansion of its sales operations by tripling its sales force and creating four specialized teams to accelerate growth and market reach for its innovative Adialabs products. Thi...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Identifies Over 20 Million Potentially Improperly Issued Shares and Initiates Process to Return Shares to Treasury
News Preview
Winter Park, Florida--(Newsfile Corp. - September 4, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on advancing stem cell therapies for orthopedics, pain management, wound repair, and regenerative medicine, today announced that it has identified over 20 million shares that may have been improperly issued as part of an...
Themefolio
Profiler
Peergroup
© Newsfile
02.09.2025
ADIA
LISTED
OTC
Adia Med Finalizing In-Network Access with the Nation's Largest Health Insurers Including Medicare, Medicaid, Humana, Cigna, and Florida Blue
News Preview
Winter Park, Florida--(Newsfile Corp. - September 2, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in regenerative medicine, is thrilled to announce a transformative step toward expanding patient access to its innovative stem cell therapies. The company is finalizing in-network provider status with some of the nation's largest health ins...
Themefolio
Profiler
Peergroup
© Newsfile
28.08.2025
ADIA
LISTED
OTC
Adia Nutrition Joins PI Doctors Elite Community as Preferred Vendor Unlocking Access to a $50 Billion Personal Injury Care Market
News Preview
Winter Park, Florida--(Newsfile Corp. - August 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine and personalized healthcare, announced that its laboratory division, Adia Labs, has been selected as a preferred vendor for the PI Doctors Elite Community. This national network includes over 4,000...
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
ADIA
LISTED
OTC
Adia Med Surges Ahead of Growth Timeline With Venture Medical Partnership in $25B Wound Care Market
News Preview
Winter Park, Florida--(Newsfile Corp. - August 26, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a bold leader in regenerative medicine and personalized healthcare, today announced a thrilling partnership between its clinical division, Adia Med, and Venture Medical. This electrifying collaboration launches Adia Med into the epicenter of insurance-read...
Themefolio
Profiler
Peergroup
© Newsfile
21.08.2025
ADIA
LISTED
OTC
Adia Nutrition Launches Second National Television Campaign Showcasing U.S.-Based Regenerative Stem Cell Therapies
News Preview
Winter Park, Florida--(Newsfile Corp. - August 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized healthcare, today announced the launch of its second nationwide television campaign. The commercial highlights Adia Med, the company's clinical division, and its advanced regenerative stem...
Themefolio
Profiler
Peergroup
© Newsfile
20.08.2025
ADIA
LISTED
OTC
Adia Med Expands Into Wound Care, Targeting High-Demand $25 Billion Market and Unlocking New Growth Avenues
News Preview
Winter Park, Florida--(Newsfile Corp. - August 20, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company at the forefront of regenerative medicine and personalized health solutions, today announced that its clinical division, Adia Med, is officially expanding into the high-demand field of advanced wound care. This strategic move enab...
Themefolio
Profiler
Peergroup
© Newsfile
28.07.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Celebrates Approval as Aetna Health Insurance Provider and Anticipates United Healthcare Approval for Adia Med Subsidiary
News Preview
Winter Park, Florida--(Newsfile Corp. - July 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized wellness solutions, is thrilled to announce that its medical subsidiary, Adia Med, has been approved as an in-network provider for Aetna health insurance, effective Friday, July 25, 2025. Add...
Themefolio
Profiler
Peergroup
© Newsfile
23.07.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Supports Heroes and Their Families with TRICARE In-Network Application, Advancing Regenerative Care Through Adia Med
News Preview
Winter Park, Florida--(Newsfile Corp. - July 23, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized wellness solutions, is thrilled to announce that its medical subsidiary, Adia Med, has officially filed to become an in-network provider with TRICARE, the healthcare program serving approxima...
Themefolio
Profiler
Peergroup
© Newsfile
16.07.2025
ADIA
LISTED
OTC
Adia Nutrition Partners with CareCredit to Offer up to $25,000 in Affordable Financing for Patient Treatments
News Preview
Winter Park, Florida--(Newsfile Corp. - July 16, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine and personalized wellness solutions, is excited to announce its approval to offer CareCredit's payment plan program to patients, tapping into the $48.35 billion U.S. healthcare finance solutions market (valued in 2...
Themefolio
Profiler
Peergroup
© Newsfile
14.07.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Celebrates Grand Opening of Adia Med of San Antonio, First Licensed Clinic, Led by Michele DeLeon MD
News Preview
Winter Park, Florida--(Newsfile Corp. - July 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine, proudly announces the grand opening of Adia Med of San Antonio, its first licensed clinic under a strategic license agreement, located at 18707 Hardy Oak Blvd, Suite 500, San Antonio, Texas 78258. Headed by esteem...
Themefolio
Profiler
Peergroup
© Newsfile
02.07.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Advances Toward United Healthcare Provider Approval for Adia Med Services, Signaling Major Growth Opportunity
News Preview
Winter Park, Florida--(Newsfile Corp. - July 2, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in advanced regenerative therapies, is pleased to announce that its medical subsidiary, Adia Med, is in the final stages of approval to become an in-network provider with United Healthcare, one of the largest and most influential heal...
Themefolio
Profiler
Peergroup
© Newsfile
24.06.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Unveils Game-Changing Nationwide TV Commercial for Adia Vita: A New Era in Regenerative Medicine
News Preview
Winter Park, Florida--(Newsfile Corp. - June 24, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in the $15.1 billion global stem cell market, today ignited a revolution with the launch of its electrifying nationwide TV commercial for Adia Vita. Utilizing the innovative technology platform MNTN (NYSE: MNTN), which brings performance market...
Themefolio
Profiler
Peergroup
© Newsfile
19.06.2025
ADIA
LISTED
OTC
Timing Is Everything - Adia Nutrition Inc. Celebrates Florida's SB 1768 with Open Invitations to Adia Med Clinic
News Preview
Winter Park, Florida--(Newsfile Corp. - June 19, 2025) - Adia Nutrition Inc., (OTCQB: ADIA) a rising leader in the $15.1 billion global stem cell industry, enthusiastically welcomes Florida's Senate Bill 1768. Signed into law last month and effective July 1, 2025, this transformative legislation permits physicians to offer stem cell therapies for o...
Themefolio
Profiler
Peergroup
© Newsfile
16.06.2025
ADIA
LISTED
OTC
Home Run! Adia Med of Winter Park's AHCA Triumph Brings Insurance-Covered Healing to Patients
News Preview
Winter Park, Florida--(Newsfile Corp. - June 16, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a leading innovator in regenerative medicine and nutritional supplements, is thrilled to announce that its state-of-the-art clinic, Adia Med of Winter Park, has received full approval from the Agency for Health Care Administration (AHCA). This milestone all...
Themefolio
Profiler
Peergroup
© Newsfile
11.06.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Introduces Cherry Payment Plans at Adia Med Clinics, Enhancing Access to Innovative Therapies
News Preview
Winter Park, Florida--(Newsfile Corp. - June 11, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in healthcare and nutritional supplements, is delighted to announce the introduction of Cherry Payment Plans at its Adia Med clinics, a growing clinical chain including the flagship Adia Med of Winter Park. This innovative financing option makes cu...
Themefolio
Profiler
Peergroup
© Newsfile
09.06.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Expands Business Model with Licensing Agreements to Meet Global Demand for Adia Med's Regenerative Therapies
News Preview
Winter Park, Florida--(Newsfile Corp. - June 9, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a pioneer in regenerative medicine and nutritional supplements, is excited to announce the addition of licensing agreements to its business model, driven by strong demand from clinic owners and doctors worldwide, particularly in countries like the US, Colomb...
Themefolio
Profiler
Peergroup
© Newsfile
16.05.2025
ADIA
LISTED
OTC
CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance
News Preview
This release corrects and replaces the press release issued by Adia Nutrition Inc., on May 16, 2025, at 8:09 am EDT.Winter Park, Florida--(Newsfile Corp. - May 16, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces its successful uplisting from the OTC Pink Sheets to the OTCQB Ve...
Themefolio
Profiler
Peergroup
© Newsfile
16.05.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Files for OTCQB Uplisting with OTC Markets, Emphasizing OTC-Handled 15c2-11 for Transparency and Investor Reach
News Preview
Winter Park, Florida--(Newsfile Corp. - May 16, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces that it has officially filed with OTC Markets Group for uplisting to the OTCQB Venture Market. This filing follows the successful completion of an independent audit with Astra Au...
Themefolio
Profiler
Peergroup
© Newsfile
05.05.2025
ADIA
LISTED
OTC
Adia Nutrition Announces Major Share Structure Overhaul with Retirement of Approximately 15 Million Shares and Cancellation of 10 Million Share Commitment
News Preview
Winter Park, Florida--(Newsfile Corp. - May 5, 2025) - Adia Nutrition, Inc. (OTC Pink: ADIA), a Winter Park, Florida-based innovator in health and wellness, is excited to announce a transformative overhaul of its share structure, including the retirement of approximately 15 million shares, reducing the outstanding common stock from 95,899,861 to 80...
Themefolio
Profiler
Peergroup
© Newsfile
14.04.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Files for OTCQB Uplisting with OTC Markets, Emphasizing OTC-Handled 15c2-11 for Transparency and Investor Reach
News Preview
Winter Park, Florida--(Newsfile Corp. - April 14, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces that it has officially filed with OTC Markets Group for uplisting to the OTCQB Venture Market. This filing follows the successful completion of an independent audit with Astra...
Themefolio
Profiler
Peergroup
© Newsfile
07.04.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Completes Independent Audit with Astra Audit and Advisory LLC., Prepares to File for OTCQB Uplisting
News Preview
Winter Park, Florida--(Newsfile Corp. - April 7, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a pioneering force in advanced stem cell therapies and nutritional wellness, is proud to announce the successful completion of its independent audit, a crucial milestone that positions the company to file for uplisting to the OTCQB market. This achievemen...
Themefolio
Profiler
Peergroup
© Newsfile
01.04.2025
ADIA
LISTED
OTC
Judge Orders Cancellation of Over 25 Million Adia Nutrition Shares, Bolstering Shareholder Value
News Preview
Winter Park, Florida--(Newsfile Corp. - April 1, 2025) - Adia Nutrition (OTC Pink: ADIA), a leader in innovative nutritional solutions, is pleased to announce a significant milestone for its shareholders following a recent court ruling. A judge has ordered the cancellation of over 25 million shares of Adia Nutrition stock, including more than 15 mi...
Themefolio
Profiler
Peergroup
© Newsfile
27.03.2025
ADIA
LISTED
OTC
Adia Nutrition Inc. Opens First Satellite Location in Tinton Falls, NJ, Partnering with Keep Glowing Medical Spa and Dr. Michael Ellis
News Preview
Winter Park, Florida--(Newsfile Corp. - March 27, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and healthcare innovation, is excited to announce the opening of its first satellite location in Tinton Falls, New Jersey. This expansion is made possible through a strategic shared space agreement with Keep Glowing Medi...
Themefolio
Profiler
Peergroup
© Newsfile
25.03.2025
ADIA
LISTED
OTC
Adia Med Explores International Expansion Following Global Interest in Its Innovative Umbilical Cord Blood Stem Cell Therapies
News Preview
Winter Park, Florida--(Newsfile Corp. - March 25, 2025) - Adia Nutrition (OTC Pink: ADIA), a trailblazer in advanced healthcare solutions, is excited to announce that its subsidiary, Adia Med, is actively exploring international expansion after receiving significant interest from multiple international groups. Over recent months, several organizati...
Themefolio
Profiler
Peergroup
© Newsfile
20.03.2025
ADIA
LISTED
OTC
Adia Med Leads Charge to Standardize Umbilical Cord Stem Cell Use Nationwide, Prepares Presentation for New Head of DHHS and FDA
News Preview
Winter Park, Florida--(Newsfile Corp. - March 20, 2025) - Adia Med, a division of ADIA Nutrition Inc. (OTC Pink: ADIA), is driving a transformative effort to standardize umbilical cord stem cell use across the United States, prioritizing quality, safety, and accountability. This initiative sets rigorous best practices, mandates third-party verifica...
Themefolio
Profiler
Peergroup
© Newsfile
17.03.2025
ADIA
LISTED
OTC
Adia Med to Expand Treatment Offerings with Therapeutic Plasma Exchange (TPE) Across All Future Full Clinic Locations
News Preview
Winter Park, Florida--(Newsfile Corp. - March 17, 2025) - Adia Nutrition (OTC Pink: ADIA), a leader in innovative healthcare solutions, is thrilled to announce that its subsidiary, Adia Med, will ensure that all future full clinic locations across the United States will offer Therapeutic Plasma Exchange (TPE), with its current location already offe...
Themefolio
Profiler
Peergroup
© Newsfile
13.03.2025
ADIA
LISTED
OTC
Adia Nutrition Hunts for Top Sales Talent to Power Adia Med and Adia Labs Expansion
News Preview
Unleashing the Future of Stem Cell Therapy and Regenerative Medicine Across the U.S.Winter Park, Florida--(Newsfile Corp. - March 13, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in health, wellness, and regenerative medicine, is thrilled to announce it is recruiting dynamic sales representatives for its subsidiaries, Adia Med and Ad...
Themefolio
Profiler
Peergroup
© Newsfile
11.03.2025
ADIA
LISTED
OTC
ADIA Nutrition Strengthens Team to Optimize Operations and Advance Regenerative Medicine Excellence
News Preview
Winter Park, Florida--(Newsfile Corp. - March 11, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in healthcare innovation and regenerative medicine, is proud to announce the expansion of its workforce with two strategic hires designed to enhance operations and elevate standards in stem cell therapy. These additions reflect ADIA Nutrition's...
Themefolio
Profiler
Peergroup
© Newsfile
05.03.2025
ADIA
LISTED
OTC
Adia Nutrition Moves to Secure Brand Identity with Trademark Filings
News Preview
Winter Park, Florida--(Newsfile Corp. - March 5, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a frontrunner in health and wellness innovation, is fortifying its brand legacy by filing trademark applications with the U.S. Patent and Trademark Office (USPTO) for its new product, "Adia Vita," and its bold slogan, "The Platinum Standard in Stem Cell T...
Themefolio
Profiler
Peergroup
© Newsfile
03.03.2025
ADIA
LISTED
OTC
Adia Labs Secures FDA Registration for Adia Vita, Expands Regenerative Medicine Nationwide
News Preview
Winter Park, Florida--(Newsfile Corp. - March 3, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare innovation, proudly announces a major milestone for its new subsidiary, Adia Labs LLC: the FDA has accepted the registration of Adia Vita. This acceptance reflects Adia Labs' notification to the FDA that it will be storing and...
Themefolio
Profiler
Peergroup
© Newsfile
28.02.2025
ADIA
LISTED
OTC
ADIA Nutrition Inc. Ignites 2025 with February Breakthroughs, Riding Adia Med's Profitable January Triumph
News Preview
Winter Park, Florida--(Newsfile Corp. - February 28, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a pioneer in healthcare innovation and regenerative medicine, concludes an extraordinary February with groundbreaking advancements in stem cell therapies, strategic partnerships, and a pivotal corporate milestone. These achievements, layered atop Janu...
Themefolio
Profiler
Peergroup
© Newsfile
26.02.2025
ADIA
LISTED
OTC
Adia Nutrition Announces Successful Removal of Shell Risk Designation by OTC Markets, Advancing Toward OTCQB Uplisting
News Preview
Winter Park, Florida--(Newsfile Corp. - February 26, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in innovative nutritional products and regenerative medical treatments, is excited to announce that it has successfully removed its shell risk designation from OTC Markets, a pivotal achievement on its accelerated journey to uplist from the O...
Themefolio
Profiler
Peergroup
© Newsfile
24.02.2025
ADIA
LISTED
OTC
ADIA Nutrition Inc. Embarks on Nationwide Expansion of Adia Med Satellite Locations
News Preview
Winter Park, Florida--(Newsfile Corp. - February 24, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in healthcare innovation and regenerative medicine, proudly announces its strategic expansion plan for Adia Med satellite locations across the United States. This initiative aims to make Adia Med's innovative treatments more accessible by par...
Themefolio
Profiler
Peergroup
© Newsfile
24.02.2025
ADIA
LISTED
OTC
ADIA Nutrition Inc. Embarks on Nationwide Expansion of Adia Med Satellite Locations
News Preview
Winter Park, Florida--(Newsfile Corp. - February 24, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in healthcare innovation and regenerative medicine, proudly announces its strategic expansion plan for Adia Med satellite locations across the United States. This initiative aims to make Adia Med's innovative treatments more accessible by par...
Themefolio
Profiler
Peergroup
© Newsfile
20.02.2025
ADIA
LISTED
OTC
ADIA Nutrition Proudly Launches Adia Labs LLC and Begins Sales of Branded Stem Cell Products
News Preview
Winter Park, Florida--(Newsfile Corp. - February 20, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare and supplementation, proudly announces the launch of Adia Labs LLC, a new division dedicated to advancing regenerative medicine. This initiative underscores ADIA Nutrition's commitment to providing high-quality products fo...
Themefolio
Profiler
Peergroup
© Newsfile
18.02.2025
ADIA
LISTED
OTC
Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products
News Preview
Winter Park, Florida--(Newsfile Corp. - February 18, 2025) - Adia (OTC Pink: ADIA) Med is proud to announce a strategic partnership with an FDA-approved laboratory in the field of regenerative medicine. This collaboration marks a new era in the availability of top-tier, third-party verified, and minimally manipulated umbilical cord stem cell and ex...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
